Scientific and Medical Equipment House Company (TADAWUL:4014)
Saudi Arabia · Delayed Price · Currency is SAR 29.50
-0.14 (-0.47%)
Jul 2, 2026, 3:15 PM AST
TADAWUL:4014 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 847.06 | 876.71 | 877.23 | 776.67 | 713.82 | 699.45 | |
Revenue Growth (YoY) | -4.05% | -0.06% | 12.95% | 8.80% | 2.05% | 13.28% |
Cost of Revenue | 733.62 | 755.14 | 744.07 | 647.92 | 560.04 | 546.7 |
Gross Profit | 113.44 | 121.56 | 133.16 | 128.75 | 153.78 | 152.75 |
Selling, General & Admin | 78.48 | 80.85 | 82.9 | 75.69 | 78.18 | 65.89 |
Operating Expenses | 82.25 | 85.17 | 78.33 | 54.18 | 117.61 | 70.36 |
Operating Income | 31.19 | 36.39 | 54.83 | 74.56 | 36.17 | 82.39 |
Interest Expense | -15.08 | -15.12 | -25.32 | -24.91 | -19.65 | -12.95 |
Interest & Investment Income | - | - | - | - | 0.05 | 0.33 |
Other Non Operating Income (Expenses) | 22.3 | 18.07 | 16.17 | 12.5 | 11.08 | 14.84 |
EBT Excluding Unusual Items | 38.41 | 39.34 | 45.67 | 62.15 | 27.65 | 84.62 |
Gain (Loss) on Sale of Assets | 0.93 | 0.83 | 0.22 | 0.01 | 0.09 | 0.22 |
Pretax Income | 39.55 | 40.17 | 45.89 | 62.16 | 27.74 | 84.83 |
Income Tax Expense | 12.68 | 13.95 | 14.65 | 15.14 | 12.12 | 8.09 |
Earnings From Continuing Operations | 26.87 | 26.21 | 31.23 | 47.02 | 15.62 | 76.75 |
Earnings From Discontinued Operations | - | - | -6.63 | -9.22 | - | - |
Net Income to Company | 26.87 | 26.21 | 24.61 | 37.8 | 15.62 | 76.75 |
Minority Interest in Earnings | 2.16 | 2.23 | 1.56 | 2.26 | 1.95 | 0.78 |
Net Income | 29.03 | 28.44 | 26.17 | 40.06 | 17.57 | 77.52 |
Net Income to Common | 29.03 | 28.44 | 26.17 | 40.06 | 17.57 | 77.52 |
Net Income Growth | 15.71% | 8.68% | -34.67% | 128.04% | -77.34% | 3.70% |
Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | 30 |
Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | 30 |
EPS (Basic) | 0.97 | 0.95 | 0.87 | 1.34 | 0.59 | 2.58 |
EPS (Diluted) | 0.97 | 0.95 | 0.87 | 1.34 | 0.59 | 2.58 |
EPS Growth | 15.71% | 8.68% | -34.67% | 128.04% | -77.34% | 3.70% |
Free Cash Flow | 0.18 | 1.67 | 281.35 | -155.51 | 133.46 | -79.49 |
Free Cash Flow Per Share | 0.01 | 0.06 | 9.38 | -5.18 | 4.45 | -2.65 |
Dividend Per Share | - | - | 1.000 | 1.000 | - | 0.667 |
Dividend Growth | - | - | - | - | - | -33.33% |
Gross Margin | 13.39% | 13.87% | 15.18% | 16.58% | 21.54% | 21.84% |
Operating Margin | 3.68% | 4.15% | 6.25% | 9.60% | 5.07% | 11.78% |
Profit Margin | 3.43% | 3.24% | 2.98% | 5.16% | 2.46% | 11.08% |
Free Cash Flow Margin | 0.02% | 0.19% | 32.07% | -20.02% | 18.70% | -11.36% |
EBITDA | 40.62 | 46.08 | 65.25 | 85.87 | 47.73 | 91.47 |
EBITDA Margin | 4.79% | 5.26% | 7.44% | 11.06% | 6.69% | 13.08% |
D&A For EBITDA | 9.43 | 9.69 | 10.42 | 11.31 | 11.56 | 9.08 |
EBIT | 31.19 | 36.39 | 54.83 | 74.56 | 36.17 | 82.39 |
EBIT Margin | 3.68% | 4.15% | 6.25% | 9.60% | 5.07% | 11.78% |
Effective Tax Rate | 32.07% | 34.73% | 31.94% | 24.35% | 43.70% | 9.53% |
Advertising Expenses | - | 1.85 | 0.03 | 0.01 | 0.27 | 0.22 |